AOHE: manuscript AOHE-D-16-00564 paroxysmal nocturnal hemoglobinuria with autoimmune hemolytic anemia following eculizumab therapy-with large granular lymphocytic leukemia

Ann Hematol. 2016 Oct;95(10):1747-9. doi: 10.1007/s00277-016-2752-5. Epub 2016 Jul 23.

Authors

Nathan Visweshwar¹, Michael Jaglal², Cassie Booth³, Patrick Griffin², Damian Laber²

Affiliations

¹ Department of Hematology, University of South Florida, 13330 USF Laurel Drive Tampa, Tampa, FL, 33612, USA. nviswesh@health.usf.edu.
² Moffitt Cancer Center, Tampa, FL, USA.
³ Tampa General Hospital, Tampa, FL, USA.

No abstract available

Publication types

Letter

MeSH terms

Anemia, Hemolytic, Autoimmune / drug therapy
Anemia, Hemolytic, Autoimmune / etiology
Anemia, Hemolytic, Autoimmune / surgery
Antibodies, Monoclonal, Humanized / therapeutic use*
Disease Progression
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
Hemoglobinuria, Paroxysmal / blood
Hemoglobinuria, Paroxysmal / complications
Hemoglobinuria, Paroxysmal / drug therapy*
Humans
Immunosuppressive Agents / therapeutic use
Leukemia, Large Granular Lymphocytic / etiology*
Leukemia, Large Granular Lymphocytic / genetics
Male
Middle Aged
Rituximab / therapeutic use
Splenectomy

Substances

Antibodies, Monoclonal, Humanized
Immunosuppressive Agents
Rituximab
eculizumab